The session aims at empowering trainers to efficient use of Multiple- Response Questions (MRQs) for education of participants towards knowledge and self awareness about endocrine disrupting chemicals (EDCs). The participants will comprise health sector professionals, policymakers, scientists and others. The trainers are those among the stakeholders who have practised themselves self-questioning about EDCs and can provide examples based on their experience and literature appraisal. The MRQs do not aim at evaluation of knowledge about EDCs; they aim at building knowledge and criticism through discussion about the possible responses. It is proposed that a question administered at the very beginning and again at the very end of the session helps in assessment of the learner chief concern and possible change following the learning session.
The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire